Emerson Electric Co. [EMR] Revenue clocked in at $18.91 billion, down -14.22% YTD: What’s Next?

Related

Emerson Electric Co. [NYSE: EMR] stock went on an upward path that rose over 0.78% on Wednesday, amounting to a one-week price decrease of less than -2.17%. The company report on June 30, 2022 that Emerson Strengthens Leadership in Life Sciences Industry with Acquisition of Fluxa.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


Acquisition complements Emerson’s software and technology portfolio and helps accelerate delivery of life-saving medicines.

Emerson (NYSE: EMR) today announced it has acquired Fluxa, a leader in the life sciences industry that uses software and modern technology architectures to accelerate the speed to market for new therapies, drugs and vaccines. The acquisition builds on Emerson’s leading software and solutions portfolio and life sciences expertise. Emerson made an equity investment in Fluxa, which is based in Glendale, California, in 2021.

Over the last 12 months, EMR stock dropped by -16.67%. The one-year Emerson Electric Co. stock forecast points to a potential upside of 24.7. The average equity rating for EMR stock is currently 2.20, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $46.89 billion, with 593.30 million shares outstanding and 589.63 million shares in the current float. Compared to the average trading volume of 3.09M shares, EMR stock reached a trading volume of 3100260 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Emerson Electric Co. [EMR]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EMR shares is $105.91 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EMR stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Oppenheimer have made an estimate for Emerson Electric Co. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 09, 2022. While these analysts kept the previous recommendation, Bernstein raised their target price to Mkt Perform. The new note on the price target was released on January 11, 2022, representing the official price target for Emerson Electric Co. stock. Previously, the target price had yet another raise from $104 to $116, while RBC Capital Mkts kept a Outperform rating on EMR stock.

The Average True Range (ATR) for Emerson Electric Co. is set at 2.29, with the Price to Sales ratio for EMR stock in the period of the last 12 months amounting to 2.48. The Price to Book ratio for the last quarter was 4.48, with the Price to Cash per share for the same quarter was set at 11.79. Price to Free Cash Flow for EMR in the course of the last twelve months was 41.72 with Quick ratio for the last quarter at 1.40.

EMR Stock Performance Analysis:

Emerson Electric Co. [EMR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.17. With this latest performance, EMR shares dropped by -11.66% in over the last four-week period, additionally sinking by -13.09% over the last 6 months – not to mention a drop of -16.67% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EMR stock in for the last two-week period is set at 40.22, with the RSI for the last a single of trading hit 40.47, and the three-weeks RSI is set at 40.48 for Emerson Electric Co. [EMR]. The present Moving Average for the last 50 days of trading for this stock 85.51, while it was recorded at 79.86 for the last single week of trading, and 92.30 for the last 200 days.

Insight into Emerson Electric Co. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Emerson Electric Co. [EMR] shares currently have an operating margin of +16.67 and a Gross Margin at +39.59. Emerson Electric Co.’s Net Margin is presently recorded at +12.63.

Return on Total Capital for EMR is now 18.09, given the latest momentum, and Return on Invested Capital for the company is 14.77. Return on Equity for this stock inclined to 25.19, with Return on Assets sitting at 9.68. When it comes to the capital structure of this company, Emerson Electric Co. [EMR] has a Total Debt to Total Equity ratio set at 73.19. Additionally, EMR Total Debt to Total Capital is recorded at 42.26, with Total Debt to Total Assets ending up at 29.27. Long-Term Debt to Equity for the company is recorded at 62.79, with the Long-Term Debt to Total Capital now at 36.26.

Reflecting on the efficiency of the workforce at the company, Emerson Electric Co. [EMR] managed to generate an average of $26,563 per employee. Receivables Turnover for the company is 5.40 with a Total Asset Turnover recorded at a value of 0.77.Emerson Electric Co.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.70.

EMR Stock EPS

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EMR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Emerson Electric Co. go to 10.33%.

Emerson Electric Co. [EMR] Insider Position Details

There are presently around $36,936 million, or 76.10% of EMR stock, in the hands of institutional investors. The top three institutional holders of EMR stocks are: VANGUARD GROUP INC with ownership of 56,160,568, which is approximately 2.875% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 41,087,166 shares of the stock with an approximate value of $3.25 billion in EMR stocks shares; and STATE STREET CORP, currently with $2.13 billion in EMR stock with ownership of nearly -0.92% of the company’s market capitalization.

Positions in Emerson Electric Co. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 855 institutional holders increased their position in Emerson Electric Co. [NYSE:EMR] by around 38,785,189 shares. Additionally, 812 investors decreased positions by around 33,595,740 shares, while 320 investors held positions by with 394,398,503 shares. The mentioned changes placed institutional holdings at 466,779,432 shares, according to the latest SEC report filing. EMR stock had 135 new institutional investments in for a total of 4,778,724 shares, while 130 institutional investors sold positions of 5,517,940 shares during the same period.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]